Matrix Biomed And Apexbio

matrix protein (3-15) [Zaire ebolavirus]

A1080-1 ApexBio 1 mg 129.6 EUR
Description: Matrix protein (3-15) is a peptide of the structure proteins linking the viral envelope with theZaireebolavirus core.Ebola virus (EBOV) is a member of the familyFiloviridaein the orderMononegavirales.

Apexbio Reagents Laboratories manufactures the matrix biomed and apexbio reagents distributed by Genprice. The Matrix Biomed And Apexbio reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Apexbio Reagents. Other Matrix products are available in stock. Specificity: Matrix Category: Biomed Group: And Apexbio

HDL and LDL/VLDL Quantification Colorimetric/Fluorometric Kit

ApexBio 100 assays 835.2 EUR

Total Cholesterol and Cholesteryl Ester Colorimetric Assay Kit II

ApexBio 100 assays 634.8 EUR

Total Cholesterol and Cholesteryl Ester Colorimetric/Fluorometric Assay Kit

ApexBio 100 assays 652.8 EUR

CX-5461

ApexBio 50 mg 811.2 EUR
Description: CX-5461 is a potent and orally bioavailable small-molecule inhibitor of rRNA synthesis that specifically inhibits RNA polymerase (Pol) I-driven transcription with IC50 value of 142 nM.

CX-5461

ApexBio Evaluation Sample 97.2 EUR
Description: CX-5461 is a potent and orally bioavailable small-molecule inhibitor of rRNA synthesis that specifically inhibits RNA polymerase (Pol) I-driven transcription with IC50 value of 142 nM.

NSC 74859

ApexBio 10 mg 157.2 EUR
Description: S3I-201 is a selective inhibitor of Stat3 with IC50 value of 86 ?M [1].In the in vitro Stat3 DNA-binding assay, S3I-201 showed potent inhibition of the Stat3 DNA-binding activity with an average IC50 of 86 ?M.

NSC 74859

ApexBio 200 mg 793.2 EUR
Description: S3I-201 is a selective inhibitor of Stat3 with IC50 value of 86 ?M [1].In the in vitro Stat3 DNA-binding assay, S3I-201 showed potent inhibition of the Stat3 DNA-binding activity with an average IC50 of 86 ?M.

And Apexbio information

SARS Matrix Peptide

3529P ProSci 0.05 mg 197.7 EUR
Description: (CT) SARS Matrix peptide

Bone Matrix Proteins

20-abx265965 Abbexa
  • 460.80 EUR
  • 710.40 EUR
  • 360.00 EUR
  • 10 mg
  • 25 mg
  • 5 mg

MATRIX 1250UL TIP

MTX-1250-C CORNING 500/pk 285.6 EUR
Description: Non Filter Tips; Pipette Tips - Axygen

MATRIX 1250UL TIP

MTX-1250-C-R CORNING 1152/pk 265.2 EUR
Description: Non Filter Tips; Pipette Tips - Axygen

Matrix Tips 1250ul

MAT8042 Scientific Laboratory Supplies PK960 213.18 EUR

Acids Matrix Spike

CLPS-MSA Scientific Laboratory Supplies 1ML 120.84 EUR

Cartilage Dissociation System 2 (Articular cartilage, Chondrocytes, Matrix vesicles, Wing buds), Mouse and Rat

4-20232 CHI Scientific ea Ask for price

Matrix protein Polyclonal Antibody

42629-100ul SAB 100ul 399.6 EUR

SARS-CoV Matrix Antibody

3527-002mg ProSci 0.02 mg 206.18 EUR
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4).

SARS-CoV Matrix Antibody

3527-01mg ProSci 0.1 mg 523.7 EUR
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4).

SARS-CoV Matrix Antibody

3529-002mg ProSci 0.02 mg 206.18 EUR
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2).The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4).

SARS-CoV Matrix Antibody

3529-01mg ProSci 0.1 mg 523.7 EUR
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2).The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4).

Influenza A antibody (Matrix)

20C-CR1235GP Fitzgerald 1 ml 501.6 EUR
Description: Goat polyclonal Influenza A antibody (Matrix)

Matrix Metalloproteinase-8 Enzyme

20-abx073423 Abbexa
  • 4101.60 EUR
  • 393.60 EUR
  • 276.00 EUR
  • 1 mg
  • 20 ug
  • 5 ug

Matrix Metalloproteinase-28 (Recombinant)

20-abx073425 Abbexa
  • 4101.60 EUR
  • 393.60 EUR
  • 276.00 EUR
  • 1 mg
  • 20 ug
  • 5 ug

Matrix Metallopeptidase 23B (Recombinant)

20-abx073584 Abbexa
  • 5388.00 EUR
  • 393.60 EUR
  • 276.00 EUR
  • 1 mg
  • 20 ug
  • 5 ug

Matrix Metalloproteinase-9 (Recombinant)

20-abx073656 Abbexa
  • 393.60 EUR
  • 7108.80 EUR
  • 276.00 EUR
  • 10 ug
  • 1 mg
  • 2 µg